Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011. https://doi.org/10.1016/S0140-6736(06)69208-8
Faggiano P, Antonini-Canterin F, Baldessin F, Lorusso R, Daloia A, Cas LD (2006) Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound 4:27. https://doi.org/10.1186/1476-7120-4-27
Article PubMed PubMed Central Google Scholar
Osnabrugge RL, Mylotte D, Head SJ et al (2013) Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 62(11):1002–1012. https://doi.org/10.1016/j.jacc.2013.05.015
Popma JJ, Deeb GM, Yakubov SJ et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380(18):1706–1715. https://doi.org/10.1056/NEJMoa1816885
Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376(14):1321–1331. https://doi.org/10.1056/NEJMoa1700456
Makkar RR, Thourani VH, Mack MJ et al (2020) Five-Year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med 382(9):799–809. https://doi.org/10.1056/NEJMoa1910555
Winter MP, Bartko P, Hofer F et al (2020) Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies. Sci Rep 10(1):15568. https://doi.org/10.1038/s41598-020-72453-1
Article CAS PubMed PubMed Central Google Scholar
Arsalan M, Weferling M, Hecker F et al (2018) TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention 13(13):1520–1526. https://doi.org/10.4244/EIJ-D-17-00421
Wolff G, Shamekhi J, Al-Kassou B et al (2021) Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients. Clin Res Cardiol 110(3):368–376. https://doi.org/10.1007/s00392-020-01731-9
Myhre PL, Liu Y, Kulac IJ et al (2023) Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan. Eur J Heart Fail 25(8):1396–1405. https://doi.org/10.1002/ejhf.2957
Article CAS PubMed Google Scholar
Spoto S, Argemi J, Di Costanzo R et al (2023) Mid-Regional pro-adrenomedullin and N-Terminal Pro-B-Type natriuretic peptide measurement: a multimarker approach to diagnosis and prognosis in acute heart failure. J Pers Med. https://doi.org/10.3390/jpm13071155
Article PubMed PubMed Central Google Scholar
Hirano S, Imamura T, Matsuo T et al (2000) Differential responses of circulating and tissue adrenomedullin and gene expression to volume overload. J Card Fail 6(2):120–129. https://doi.org/10.1054/jcaf.2000.7277
Article CAS PubMed Google Scholar
Voors AA, Kremer D, Geven C et al (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21(2):163–171. https://doi.org/10.1002/ejhf.1366
Article CAS PubMed Google Scholar
Kempf T, von Haehling S, Peter T et al (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50(11):1054–1060. https://doi.org/10.1016/j.jacc.2007.04.091
Article CAS PubMed Google Scholar
Kempf T, Wollert KC (2009) Growth-differentiation factor-15 in heart failure. Heart Fail Clin 5(4):537–547. https://doi.org/10.1016/j.hfc.2009.04.006
Kempf T, Zarbock A, Widera C et al (2011) GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 17(5):581–588. https://doi.org/10.1038/nm.2354
Article CAS PubMed Google Scholar
Vahanian A, Beyersdorf F, Praz F et al (2022) ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 43(7):561–632. https://doi.org/10.1093/eurheartj/ehab395
Writing Committee M, Otto CM, Nishimura RA et al (2020) ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 77(4):450–500. https://doi.org/10.1016/j.jacc.2020.11.035
Nashef SA, Roques F, Sharples LD et al (2012) EuroSCORE II. Eur J Cardiothorac Surg 41(4):734–744. https://doi.org/10.1093/ejcts/ezs043
O’Brien SM, Shahian DM, Filardo G et al (2009) The society of thoracic surgeons 2008 cardiac surgery risk models: part 2–isolated valve surgery. Ann Thorac Surg 88(1 Suppl):S23-42. https://doi.org/10.1016/j.athoracsur.2009.05.056
Barili F, Pacini D, Capo A et al (2013) Does EuroSCORE II perform better than its original versions? A multicentre validation study. Eur Heart J 34(1):22–29. https://doi.org/10.1093/eurheartj/ehs342
Holmes DR Jr, Nishimura RA, Grover FL et al (2015) Annual outcomes with transcatheter valve therapy: from the sts/acc tvt registry. J Am Coll Cardiol 66(25):2813–2823. https://doi.org/10.1016/j.jacc.2015.10.021
Edwards FH, Cohen DJ, O’Brien SM et al (2016) Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement. JAMA Cardiol 1(1):46–52. https://doi.org/10.1001/jamacardio.2015.0326
Debonnaire P, Fusini L, Wolterbeek R et al (2015) Value of the “TAVI2-SCORe” versus surgical risk scores for prediction of one year mortality in 511 patients who underwent transcatheter aortic valve implantation. Am J Cardiol 115(2):234–242. https://doi.org/10.1016/j.amjcard.2014.10.029
Kotting J, Schiller W, Beckmann A et al (2013) German Aortic Valve Score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43(5):971–977. https://doi.org/10.1093/ejcts/ezt114
Seoudy H, Frank J, Neu M et al (2019) Periprocedural changes of NT-proBNP are associated with survival after transcatheter aortic valve implantation. J Am Heart Assoc 8(3):e010876. https://doi.org/10.1161/JAHA.118.010876
Article CAS PubMed PubMed Central Google Scholar
Mizutani K, Hara M, Iwata S et al (2017) Elevation of B-Type natriuretic peptide at discharge is associated with 2-Year mortality after transcatheter aortic valve replacement in patients with severe aortic stenosis: insights from a multicenter prospective OCEAN-TAVI (optimized transcatheter valvular intervention-transcatheter aortic valve implantation) registry. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.006112
Article PubMed PubMed Central Google Scholar
Akodad M, Spaziano M, Chevalier B et al (2019) Prognostic impact of pre-transcatheter and post-transcatheter aortic valve intervention troponin: a large cohort study. J Am Heart Assoc 8(6):e011111. https://doi.org/10.1161/JAHA.118.011111
Article PubMed PubMed Central Google Scholar
Kohler WM, Freitag-Wolf S, Lambers M et al (2016) Preprocedural but not periprocedural high-sensitive Troponin T levels predict outcome in patients undergoing transcatheter aortic valve implantation. Cardiovasc Ther 34(6):385–396. https://doi.org/10.1111/1755-5922.12208
Article CAS PubMed Google Scholar
Tada H, Fujino N, Nomura A et al (2021) Personalized medicine for cardiovascular diseases. J Hum Genet 66(1):67–74. https://doi.org/10.1038/s10038-020-0818-7
留言 (0)